Abstract
Basaloid squamous cell carcinoma (BSCC), a variant of squamous cell carcinoma (SCC), is a rare and aggressive epithelial malignancy which has been reported in only 0.1–11 % of primary esophageal carcinomas. In this study, a comparison of clinicopathological features and protein expression between esophageal BSCC (EBSCC) and conventional esophageal SCC (ESCC) cases from Brazil was performed in order to find factors that can be relevant to better characterize EBSCC. The expression of HER2, epidermal growth factor receptor (EGFR), Ki-67, and cyclins (A, B1, and D1) in 111 cases (95 ESCC and 16 EBSCC) was evaluated by immunohistochemistry using tissue microarray. When the clinicopathological data were compared, no significant difference was found between the two histological types. Although the difference is not significant (p = 0.055), the EGFR expression was more frequent in the conventional ESCC than in the EBSCC group. Our results indicate that the clinicopathological profiles of conventional ESCC and EBSCC are similar and provide no indicators for differences in prognosis between these two groups.
Similar content being viewed by others
References
Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg. 1995;222:654–62.
Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205–11.
Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg. 2005;189:98–109.
Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17:1158–66.
Cho KJ, Jang JJ, Lee SS, Zo JI. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation. Histopathology. 2000;36:331–40.
Bellizzi AM, Woodford RL, Moskaluk CA, Jones DR, Kozower BD, Stelow EB. Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers. Am J Surg Pathol. 2009;33:1608–14.
Chen S-B, Weng H-R, Wang G, Yang J-S, Yang W-P, Li H, et al. Basaloid squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol. 2012;138:1165–71.
Kobayashi Y, Nakanishi Y, Taniguchi H, Sekine S, Igaki H, Tachimori Y, et al. Histological diversity in basaloid squamous cell carcinoma of the esophagus. Dis Esophagus Off J Int Soc Dis Esophagus ISDE. 2009;22:231–8.
Zhang B-H, Cheng G-Y, Xue Q, Gao S-G, Sun K-L, Wang Y-G, et al. Clinical outcomes of basaloid squamous cell carcinoma of the esophagus: a retrospective analysis of 142 cases. Asian Pac J Cancer Prev APJCP. 2013;14:1889–94.
Nishimura W, Naomoto Y, Hamaya K, Toda S, Miyagi K, Tanaka N. Basaloid-squamous cell carcinoma of the esophagus: diagnosis based on immunohistochemical analysis. J Gastroenterol Hepatol. 2001;16:586–90.
Noguchi H, Naomoto Y, Haisa M, Yamatsuji T, Shigemitsu K, Shirakawa Y, et al. Two cases of superficial basaloid squamous carcinoma of the esophagus. Dis Esophagus Off J Int Soc Dis Esophagus ISDE. 2003;16:342–5.
Shibata Y, Baba E, Ariyama H, Miki R, Ogami N, Arita S, et al. Metastatic basaloid-squamous cell carcinoma of the esophagus treated by 5-fluorouracil and cisplatin. World J Gastroenterol WJG. 2007;13:3634–7.
Akagi I, Miyashita M, Makino H, Nomura T, Ohkawa K, Tajiri T. Basaloid squamous cell carcinoma of the esophagus: report of two cases. J Nippon Med Sch Nippon Ika Daigaku Zasshi. 2008;75:354–60.
Nakamura M, Nishikawa J, Suenaga S, Okamoto T, Okamoto F, Miura O, et al. A case of EMRC for basaloid squamous carcinoma of the cervical esophagus. World J Gastrointest Endosc. 2012;4:373–5.
Sarbia M, Verreet P, Bittinger F, Dutkowski P, Heep H, Willers R, et al. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer. 1997;79:1871–8.
Zhang X-H, Sun G-Q, Zhou X-J, Guo H-F, Zhang T-H. Basaloid squamous carcinoma of esophagus:a clinicopathological, immunohistochemical and electron microscopic study of sixteen cases. World J Gastroenterol WJG. 1998;4:397–403.
Sarbia M, Loberg C, Wolter M, Arjumand J, Heep H, Reifenberger G, et al. Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus. Am J Pathol. 1999;155:1027–32.
Huang Z, Shen Y, Liang Y, Wu X. Basaloid squamous cell carcinoma of the esophagus: an immunohistochemical study of 8 cases. Chin Med J (Engl). 2001;114:1084–8.
Ohashi K, Horiguchi S, Moriyama S, Hishima T, Hayashi Y, Momma K, et al. Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases. Pathol Res Pract. 2003;199:713–21.
Owonikoko T, Loberg C, Gabbert HE, Sarbia M. Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study. J Pathol. 2001;193:155–61.
Koide N, Nishio A, Kono T, Hiraguri M, Watanabe H, Igarashi J, et al. Histochemical study of angiogenesis in basaloid squamous carcinoma of the esophagus. Dis Esophagus Off J Int Soc Dis Esophagus ISDE. 2000;13:142–7.
Imamhasan A, Mitomi H, Saito T, Hayashi T, Takahashi M, Kajiyama Y, et al. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Hum Pathol. 2012;43:2012–23.
Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K, et al. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem. 2003;278:1824–30.
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366:2–16.
Rowinsky EK. Signal events: cell signal transduction and its inhibition in cancer. Oncologist. 2003;8 Suppl 3:5–17.
Yam CH, Fung TK, Poon RY. Cyclin A in cell cycle control and cancer. Cell Mol Life Sci. 2002;59:1317–26.
Coqueret O. Linking cyclins to transcriptional control. Gene. 2002;299:35.
Wasch R, Engelbert D. Anaphase-promoting complex-dependent proteolysis of cell cycle regulators and genomic instability of cancer cells. Oncogene. 2005;24:1–10.
Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology. 2004;145:5439–47.
Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective. Oncogene. 2005;24:2909–15.
Murray AW. Recycling the cell cycle: cyclins revisited. Cell. 2004;116:221.
Endl E, Gerdes J. The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res. 2000;257:231–7.
Acknowledgments
The authors thank Carlos Ferreira Nascimento and Severino Ferreira da Silva for providing technical assistance. This study was supported by grants from the Fundação de Apoio a Pesquisa do Estado de São Paulo (FAPESP).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was supported by grants from the Fundação de Apoio a Pesquisa do Estado de São Paulo (FAPESP 2010/19572-6).
Conflicts of interest
None
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table S1
(DOCX 55 kb)
Supplementary Table S2
(DOCX 58 kb)
Rights and permissions
About this article
Cite this article
Sato-Kuwabara, Y., Fregnani, J.H.T.G., Jampietro, J. et al. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression. Tumor Biol. 37, 6691–6699 (2016). https://doi.org/10.1007/s13277-015-4551-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-015-4551-3